Loading companies…
Loading companies…
United States · Biotech · AI · Enterprise software
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $9.5M | Darwin Ventures — Role not disclosedNSG Ventures — Role not disclosedSEEDS — Role not disclosedTaya Venture — Role not disclosed |